LUCIDRIL Film coated tablet Ref.[50998] Active ingredients: Meclofenoxate

Source: Web Search  Publisher: Manufactured by: Minapharm Co. for, Pharmaceuticals & Chemical Industries Minapharm Egypt

Product name and form

Lucidril 250 F.C. tablets.

Pharmaceutical Form

Film coated tablets.

Qualitative and quantitative composition

Compostion Per F.C. Tablets

Active Ingredient:

Meclofenoxate Hydrochloride (freeze-dried) 250 mg.

Inactive Ingredient:

Tribasic Calcium Phosphate 95 mg
Magnesium Stearate 5 mg
Polyvinyl acetate 20 mg
Methyl Cellulose 3.5 mg
Ethyl Cellulose 0.5 mg
Dibutyl phthalate 0.75 mg
Talc 25 mg

Active Ingredient Description
Meclofenoxate

Meclofenoxate is a cholinergic nootropic with antianoxic effect whether anoxia is provoked by defect or misuse of oxygen. Meclofenoxate improves extraction and utilization of glucose from the brain which allows maintenance of storage of energy for the neuron even in case of O2 deficiency or aging. In elderly patients, meclofenoxate has been shown to improve performance on certain memory tests. Meclofenoxate also increases cellular membrane phospholipids.

List of Excipients

Tribasic calcium phosphate 95 mg
Magnesium stearate 5 mg
Polyvinyl acetate 20 mg
Methyl cellulose 3.5 mg
Ethyl cellulose 0.5 mg
Dibutyl phthalate 0.75 mg
Talc 25 mg

Pack sizes and marketing

Carton box of 20 tablets, each containing 250 mg of meclofenoxate hydrochloride.

Marketing authorization holder

Manufactured by: Minapharm Co. for, Pharmaceuticals & Chemical Industries

Minapharm – Egypt

Drugs

Drug Countries
LUCIDRIL Japan

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.